IDO1 inhibitors are compounds that selectively block the activity of indoleamine 2,3-dioxygenase 1, an enzyme involved in tryptophan metabolism and immune tolerance. These reagents support research into immune regulation, inflammation, and therapeutic interventions in immunological disorders.